234 related articles for article (PubMed ID: 18538627)
1. Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection.
Pacheco LG; Mati VL; Castro TL; Dorella FA; Oliveira SC; Miyoshi A; de Melo AL; Azevedo V
Parasitol Int; 2008 Dec; 57(4):506-8. PubMed ID: 18538627
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361
[TBL] [Abstract][Full Text] [Related]
3. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
Pacheco LG; Zucconi E; Mati VL; Garcia RM; Miyoshi A; Oliveira SC; de Melo AL; Azevedo V
Acta Trop; 2005 Aug; 95(2):132-42. PubMed ID: 15993833
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
[TBL] [Abstract][Full Text] [Related]
6. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
[TBL] [Abstract][Full Text] [Related]
8. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
[TBL] [Abstract][Full Text] [Related]
9. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
10. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
[TBL] [Abstract][Full Text] [Related]
11. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
12. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
Tendler M; Simpson AJ
Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
[TBL] [Abstract][Full Text] [Related]
13. Role of recombinent interleukin-12 as an adjuvant on vaccine-induced immunity in murine Schistosoma mansoni infection.
Abdel-Aaty HE; Ramadan NI; Mahmoud MS; Abdel-Aziz SS; Khalil HM; El-Badawy NM; Khalil HH
J Egypt Soc Parasitol; 1999; 29(1):1-11. PubMed ID: 12561877
[TBL] [Abstract][Full Text] [Related]
14. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccination using recombinant Schistosoma mansoni fatty acid binding protein (smFABP) gene.
Aly I; ELnain G; Hamad RS; Kilany M; Ghramh HA; Alshehri A; Dajem SM; Ibrahim EH
Exp Parasitol; 2018 Nov; 194():53-59. PubMed ID: 30266572
[TBL] [Abstract][Full Text] [Related]
16. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
[TBL] [Abstract][Full Text] [Related]
17. The development of hepatic granulomas in 20 Krad irradiated Schistosoma mansoni cercaria vaccinated grivet monkeys (Cercopithecus aethiops aethiops).
Torben W; Hailu A
Exp Parasitol; 2007 Dec; 117(4):376-81. PubMed ID: 17603044
[TBL] [Abstract][Full Text] [Related]
18. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
Don TA; Bethony JM; Loukas A
Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines.
Ganley-Leal LM; Guarner J; Todd CW; Da'Dara AA; Freeman GL; Boyer AE; Harn DA; Secor WE
Parasite Immunol; 2005 Sep; 27(9):341-9. PubMed ID: 16149992
[TBL] [Abstract][Full Text] [Related]
20. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni.
Marques HH; Zouain CS; Torres CB; Oliveira JS; Alves JB; Goes AM
Immunobiology; 2008; 213(5):437-46. PubMed ID: 18472052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
